In today’s recent session, 0.47 million shares of the Phio Pharmaceuticals Corp (NASDAQ:PHIO) have been traded, and its beta is 1.46. Most recently the company’s share price was $2.95, and it changed around -$0.13 or -4.22% from the last close, which brings the market valuation of the company to $2.54M. PHIO at last check was trading at a discount to its 52-week high of $29.07, offering almost -885.42% off that amount. The share price’s 52-week low was $2.40, which indicates that the recent value has risen by an impressive 18.64% since then. We note from Phio Pharmaceuticals Corp’s average daily trading volume that its 10-day average is 28160.0 shares, with the 3-month average coming to 49.00K.
Phio Pharmaceuticals Corp stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended PHIO as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. Phio Pharmaceuticals Corp is expected to report earnings per share of -4.14 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Phio Pharmaceuticals Corp (NASDAQ:PHIO) trade information
Instantly PHIO has been showing red trend so far today with a performance of -4.22% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 3.61 on recent trading dayincreased the stock’s daily price by 18.28%. The company’s shares are currently down -56.87% year-to-date, but still down -14.49% over the last five days. On the other hand, Phio Pharmaceuticals Corp (NASDAQ:PHIO) is 13.03% up in the 30-day period. We can see from the shorts that 17059.0 shares have been sold at a short interest cover period of 0.8 day(s).
Phio Pharmaceuticals Corp (PHIO) estimates and forecasts
Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 80.80% in revenue this quarter, and will report an increase of 64.90% in the next quarter.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 62.38%.
PHIO Dividends
Phio Pharmaceuticals Corp’s next quarterly earnings report is expected to be released on 2024-Nov-07.
Phio Pharmaceuticals Corp (NASDAQ:PHIO)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 5.89% of Phio Pharmaceuticals Corp shares, and 2.56% of them are in the hands of institutional investors. The stock currently has a share float of 2.72%.
